tepmetko
merck europe b.v. - tepotinib hydrochloride monohydrate - carcinom, pulmonar non-celulă mică - agenți antineoplazici - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - carcinom, pulmonar non-celulă mică - agenți antineoplazici - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
inrebic
bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - agenți antineoplazici - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.
wobenzym comprimate gastrorezistente
mucos pharma gmbh&co.kg - o combinatie - comprimate gastrorezistente
acid boric solutie cutanata 3%
farmaco sa, im - acid boricum - solutie cutanata - 3%
exodermin-unf solutie cutanata 1%
universal-farm srl - naftifinum - solutie cutanata - 1%
rebetol capsule 200 mg
schering-plough central east ag - ribavirinum - capsule - 200 mg
vagiprost 25 mcg ovule
farmaprim srl - misoprostolum - ovule - 25 mcg
lisinopril atb comprimate 10 mg
antibiotice sa, sc - lisinoprilum - comprimate - 10 mg
lisinopril atb comprimate 20 mg
antibiotice sa, sc - lisinoprilum - comprimate - 20 mg